The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C
Open accessAbstract
It is unclear whether the current antiviral treatment for chronic hepatitis C virus (HCV) infection results in complete elimination of the virus, or whether small quantities of virus persist. Our study group comprised 17 patients with chronic HCV who had sustained virological response (SVR) after interferon/ribavirin treatment. Serum and peripheral blood mononuclear cells were collected 2 to 3 times at 3- to 6-month intervals starting 40 to 109 months (mean, 64.2 ± 18.5 months) after the end of therapy. In addition, lymphocyte and macrophage cultures were established at each point. In 11 patients, frozen liver tissue samples were available from follow-up biopsies performed 41 to 98 months (mean, 63.6 ± 16.7 months) after therapy. Presence of HCV RNA was determined by sensitive reverse-transcriptase polymerase chain reaction, and concentration of positive and negative strands was determined by a novel quantitative real-time reverse transcriptase polymerase chain reaction. Only 2 of 17 patients remained consistently HCV RNA negative in all analyzed compartments. HCV RNA was detected in macrophages from 11 patients (65%) and in lymphocytes from 7 patients (41%). Viral sequences were also detected in 3 of 11 livers and in sera from 4 patients. Viral replicative forms were found in lymphocytes from 2 and in macrophages from 4 patients. In conclusion, our results suggest that in patients with SVR after therapy, small quantities of HCV RNA may persist in liver or macrophages and lymphocytes for up to 9 years. This continuous viral presence could result in persistence of humoral and cellular immunity for many years after therapy and could present a potential risk for infection reactivation. (Hepatology 2005;41:106–114.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W., & Wollman, J. (1981) · Hepatology · doi:10.1002/hep.1840010511 · Cited by 3,522
An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
Kuo, G., Choo, Q.-L., Alter, H. J., Gitnick, G. L., Redeker, A. G., Purcell, R. H., Miyamura, T., Dienstag, J. L., Alter, M. J., Stevens, C. E., et al. (1989) · Science · doi:10.1126/science.2496467 · Cited by 3,346
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,992
The Natural History of Community-Acquired Hepatitis C in the United States
Alter, M. J., Margolis, H. S., Krawczynski, K., Judson, F. N., Mares, A., Alexander, W. J., Hu, P. Y., Miller, J. K., Gerber, M. A., Sampliner, R. E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272702 · Cited by 1,592
Kiyosawa, K., Sodeyama, T., Tanaka, E., Gibo, Y., Yoshizawa, K., Nakano, Y., Furuta, S., Akahane, Y., Nishioka, K., Purcell, R. H., et al. (1990) · Hepatology · doi:10.1002/hep.1840120409 · Cited by 1,217
[Gastric adenocarcinoma and kidney transplantation].
Barrio, J., García-Bengoechea, M., Emparanza, J. I., & Arenas, J. I. (1998) · PubMed · Cited by 1,132
Rehermann, B., Ferrari, C., Pasquinelli, C., & Chisari, F. V. (1996) · Nature Medicine · doi:10.1038/nm1096-1104 · Cited by 854
HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help
Grakoui, A., Shoukry, N. H., Woollard, D. J., Han, J.-H., Hanson, H. L., Ghrayeb, J., Murthy, K. K., Rice, C. M., & Walker, C. M. (2003) · Science · doi:10.1126/science.1088774 · Cited by 830
Takaki, A., Wiese, M., Maertens, G., Depla, E., Seifert, U., Liebetrau, A., Miller, J. L., Manns, M. P., & Rehermann, B. (2000) · Nature Medicine · doi:10.1038/75063 · Cited by 739
Gerlach, J. T., Diepolder, H. M., Jung, M., Gruener, N. H., Schraut, W. W., Zachoval, R., Hoffmann, R., Schirren, C. A., Santantonio, T., & Pape, G. R. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70353-7 · Cited by 714
Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection
Bain, C., Fatmi, A., Zoulim, F., Zarski, J.-P., Trépo, C., & Inchauspé, G. (2001) · Gastroenterology · doi:10.1053/gast.2001.21212 · Cited by 410
Simonetti, R. G., Cammà, C., Fiorello, F., Cottone, M., Rapicetta, M., Marino, L., Fiorentino, G., Craxì, A., Ciccaglione, A., Giuseppetti, R., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-2-97 · Cited by 354
Hepatitis B virus persistence after recovery from acute viral hepatitis.
Michalak, T. I., Pasquinelli, C., Guilhot, S., & Chisari, F. V. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116950 · Cited by 330
Hepatitis C Virus Persistence after Spontaneous or Treatment-Induced Resolution of Hepatitis C
Pham, T. N. Q., MacParland, S. A., Mulrooney, P. M., Cooksley, H., Naoumov, N. V., & Michalak, T. I. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5867-5874.2004 · Cited by 324
Seeff, L. B., Hollinger, B. F., Alter, H. J., Wright, E. C., Cain, C. M. B., Buskell, Z. J., Ishak, K. G., Iber, F. L., Toro, D., Samanta, A., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.21905 · Cited by 321
Lanford, R. E., Sureau, C., Jacob, J. R., White, R., & Fuerst, T. R. (1994) · Virology · doi:10.1006/viro.1994.1381 · Cited by 313
Radkowski, M., Wilkinson, J., Nowicki, M., Adair, D., Vargas, H., Ingui, C., Rakela, J., & Laskus, T. (2002) · Journal of Virology · doi:10.1128/jvi.76.2.600-608.2002 · Cited by 278
Self-citationRole of macrophages in natural resistance to virus infections
Mogensen, S. C. (1979) · Microbiological Reviews · doi:10.1128/mmbr.43.1.1-26.1979 · Cited by 277
10-year follow-up after interferon-α therapy for chronic hepatitis C
Lau, D. T., Kleiner, D. E., Ghany, M. G., Park, Y., Schmid, P., & Hoofnagle, J. H. (1998) · Hepatology · doi:10.1002/hep.510280430 · Cited by 266
Lerat, H., Rumin, S., Habersetzer, F., Berby, F., Trabaud, M.-A., Trépo, C., & Inchauspé, G. (1998) · Blood · doi:10.1182/blood.v91.10.3841 · Cited by 261
Forton, D. M., Karayiannis, P., Mahmud, N., Taylor-Robinson, S. D., & Thomas, H. C. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5170-5183.2004 · Cited by 242
Laskus, T., Radkowski, M., Piasek, A., Nowicki, M., Horban, A., Cianciara, J., & Rakela, J. (2000) · The Journal of Infectious Diseases · doi:10.1086/315283 · Cited by 213
Self-citationLaskus, T., Radkowski, M., Wang, L., Vargas, H. E., & Rakela, J. L. (1998) · Hepatology · doi:10.1002/hep.510280531 · Cited by 152
Self-citationNavas, S., Martín‐García, J., Quiroga, J. A., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1640-1646.1998 · Cited by 142
Michalak, T. I., Pardoe, I. U., Coffin, C. S., Churchill, N. D., Freake, D. S., Smith, P. G., & Trelegan, C. L. (1999) · Hepatology · doi:10.1002/hep.510290329 · Cited by 141
Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin
McHutchison, J. G., Poynard, T., Esteban, R., Davis, G. L., Goodman, Z. D., Harvey, J., Ling, M.-H., Garaud, J. J., Albrecht, J. K., Patel, K., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.31870 · Cited by 116
Introduction to therapy of hepatitis C
Lindsay, K. L. (2002) · Hepatology · doi:10.1053/jhep.2002.36226 · Cited by 107
Laskus, T., Radkowski, M., Wang, L.-F., et al. (1998) · Virology · doi:10.1006/viro.1998.9269 · Cited by 83
Self-citationMeasurement of Proliferative Responses of Cultured Lymphocytes
Muul, L. M., Heine, G., Silvin, C. J., James, S. P., Candotti, F., Radbruch, A., & Worm, M. (2011) · Current Protocols in Immunology · doi:10.1002/0471142735.im0710s94 · Cited by 80
Radkowski, M., Bednarska, A., Horban, A., Stańczak, J. J., Wilkinson, J., Adair, D. M., Nowicki, M., Rakela, J., & Laskus, T. (2004) · Journal of General Virology · doi:10.1099/vir.0.19491-0 · Cited by 77
Self-citationIntroduction to therapy of hepatitis C
Lindsay, K. L. (2002) · Hepatology · doi:10.1002/hep.1840360715 · Cited by 57
Apoptosis in alcoholic hepatitis: a novel therapeutic target?
Day, C. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00110-0 · Cited by 46
Virus-lymphoid cell interactions
Oldstone, M. B. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12756 · Cited by 32
Cited by
Directed differentiation of human embryonic stem cells into functional hepatic cells†
Cai, J., Zhao, Y., Liu, Y., Ye, F., Song, Z., Qin, H., Meng, S., Chen, Y., Zhou, R., Song, X., et al. (2007) · Hepatology · doi:10.1002/hep.21582 · Cited by 634
Swain, M. G., Lai, M., Shiffman, M. L., Cooksley, W. G. E., Zeuzem, S., Dieterich, D. T., Abergel, A., Pessôa, M. G., Lin, A., Tietz, A., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.009 · Cited by 328
Eradication of Hepatitis C Virus in Patients Successfully Treated for Chronic Hepatitis C
Maylin, S., Martinot–Peignoux, M., Moucari, R., Boyer, N., Ripault, M., Cazals–Hatem, D., Giuily, N., Castelnau, C., Cardoso, A. C., Asselah, T., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.044 · Cited by 321
Flying Under the Radar: The Immunobiology of Hepatitis C
Dustin, L. B., & Rice, C. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141602 · Cited by 313
Pearlman, B. L., & Traub, N. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir076 · Cited by 261
Metadata
- Authors
- Radkowski, M., Gallegos-Orozco, J. F., Jablonska, J., Colby, T. V., Walewska-Zielecka, B., Kubicka, J., Wilkinson, J., Adair, D., Rakela, J., & Laskus, T.
- Venue
- Hepatology
- Published
- 2005-01
- Volume
- 41
- Issue
- 1
- Pages
- 106-114
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2038299336
- Cited by
- 304
- References
- 34
- FWCI
- 22.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.